Mental Health DailyResearch. Evidence. Perspective.Published research on alks 5461.
Research suggests that upwards of 16 million American adults (6.7% of the adult population) are afflicted with major depressive disorder (MDD), a neuropsychiatric condition characterized by …
Read articleFor individuals in the United States between the age of 15 and 44, major depression is the leading cause of disability. Major depression is often a heritable condition, caused by maladaptive…
Read articleThe quest to come up with a superior antidepressant is in full effect among biotech and pharmaceutical companies. Although there are some companies that are still tweaking various formulatio…
Read articleALKS-5461 is a new drug that is being developed by the company Alkermes as an alternative to SSRI’s for the treatment of depression. ALKS-5461 (its trial name) is a combination of both bupre…
Read article